Breathe Well Live Well
Condition: Widespread Chronic Pain
Interventions: Drug: Ketotifen Fumarate; Drug: Placebo; Other: Standard of Care
Sponsors: McGill University Health Center; The Louise And Alan Edwards Foundation
Recruiting – verified December 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Condition: Allergic Asthma
Intervention: Biological: Whole lung antigen challenge, segmental allergen challenge
Sponsors: University of Wisconsin, Madison; National Institutes of Health (NIH)
Not yet recruiting – verified May 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Depression; Asthma; Urticaria
Intervention: Behavioral: Brief Behavioral Activation Intervention
Sponsor: University of Mississippi Medical Center
Not yet recruiting – verified March 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
| Related Articles |
Distinct Selectivity of Gangliosides Required for CD4(+) T and CD8(+) T Cell Activation.
Biochim Biophys Acta. 2014 Sep 2;
Authors: Inokuchi JI, Nagafuku M, Ohno I, Suzuki A
Abstract
T cells compose a crucial part of the immune system and require activation. The first step of T cell activation is triggered by the movement of one of their surface molecules, known as T cell receptor, into localized regions of cell membrane known as lipid rafts. Molecules called gangliosides are known to be major components of lipid rafts, but their role in T-cell activation remains to be elucidated. This review summarizes recent findings that different types of T cells require distinct ganglioside types for the activation. Control of ganglioside expression would offer a strategy targeting for specific T-cell subpopulations to treat immune diseases. This article is part of a Special Issue entitled Linking transcription to physiology in lipodomics.
PMID: 25193136 [PubMed – as supplied by publisher]
View full post on pubmed: asthma
Condition: Skin Wrinkles on Face and Neck Areas
Intervention: Other: Activation Mist
Sponsors: California Allergy and Asthma Medical Group, Inc.; California Allergy and Asthma Medical Group, Inc.
Not yet recruiting – verified September 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Mild to Moderate Persistent Asthma
Intervention: Dietary Supplement: Activation Energy Serum
Sponsors: California Allergy and Asthma Medical Group, Inc.; California Allergy and Asthma Medical Group, Inc.
Not yet recruiting – verified September 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days